Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplement Figure 2 from Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma
Home
Publications
Supplement Figure 2 from Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma
Supplement Figure 2 from Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma
Authors:
JH
Jing Hu
Jing Hu
HZ
Huijuan Zhang
Huijuan Zhang
MC
Mengru Cao
Mengru Cao
LW
Li Wang
Li Wang
SW
Shuhong Wu
Shuhong Wu
BF
Bingliang Fang
Bingliang Fang
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
3 April 2023
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1535-7163.22504981.v1
Abstract
Relative value of PARP cleavage based on intensity of Western blot bands of Figure 3. The value was determined using software ImageJ and normalized with β-actin.
Keywords
AURANOFIN
OSIMERTINIB
Related articles
Scroll to top